{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:32:21Z","timestamp":1781332341638,"version":"3.54.1"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972399"],"award-info":[{"award-number":["61972399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Effective drugs are urgently needed to overcome human complex diseases. However, the research and development of novel drug would take long time and cost much money. Traditional drug discovery follows the rule of one drug-one target, while some studies have demonstrated that drugs generally perform their task by affecting related pathway rather than targeting single target. Thus, the new strategy of drug discovery, namely pathway-based drug discovery, have been proposed. Obviously, identifying associations between drugs and pathways plays a key role in the development of pathway-based drug discovery. Revealing the drug-pathway associations by experiment methods would take much time and cost. Therefore, some computational models were established to predict potential drug-pathway associations. In this review, we first introduced the background of drug and the concept of drug-pathway associations. Then, some publicly accessible databases and web servers about drug-pathway associations were listed. Next, we summarized some state-of-the-art computational methods in the past years for inferring drug-pathway associations and divided these methods into three classes, namely Bayesian spare factor-based, matrix decomposition-based and other machine learning methods. In addition, we introduced several evaluation strategies to estimate the predictive performance of various computational models. In the end, we discussed the advantages and limitations of existing computational methods and provided some suggestions about the future directions of the data collection and the calculation models development.<\/jats:p>","DOI":"10.1093\/bib\/bbaa061","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T11:24:17Z","timestamp":1588245857000},"source":"Crossref","is-referenced-by-count":49,"title":["Drug-pathway association prediction: from experimental results to computational models"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-4007","authenticated-orcid":false,"given":"Chun-Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-5342","authenticated-orcid":false,"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2021052111091474800_ref1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/d41573-019-00014-x","article-title":"2018 FDA drug approvals","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief Bioinform"},{"key":"2021052111091474800_ref4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamaoncol.2015.0373","article-title":"Five years of cancer drug approvals: innovation, efficacy, and costs","volume":"1","author":"Mailankody","year":"2015","journal-title":"JAMA Oncol"},{"key":"2021052111091474800_ref5","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1182\/blood-2013-03-490003","article-title":"Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a ref lection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts","volume":"121","year":"2013","journal-title":"Blood"},{"key":"2021052111091474800_ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.bi.57.070188.000245","article-title":"Sequences, sequences, and sequences","volume":"57","author":"Sanger","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"2021052111091474800_ref7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/265687a0","article-title":"Nucleotide sequence of bacteriophage \u03c6X174 DNA","volume":"265","author":"Sanger","year":"1977","journal-title":"Nature"},{"key":"2021052111091474800_ref8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cell.2016.12.015","article-title":"Implementing genome-driven oncology","volume":"168","author":"Hyman","year":"2017","journal-title":"Cell"},{"key":"2021052111091474800_ref10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrd1035","article-title":"Combinatorial compound libraries for drug discovery: an ongoing challenge","volume":"2","author":"Geysen","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt0497-328","article-title":"Combinatorial chemistry in drug discovery","volume":"15","author":"Hogan","year":"1997","journal-title":"Nat Biotechnol"},{"key":"2021052111091474800_ref12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"2021052111091474800_ref13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S1359-6446(05)03670-6","article-title":"Finding new drug targets in the 21st century","volume":"10","author":"Lindsay","year":"2005","journal-title":"Drug Discov Today"},{"key":"2021052111091474800_ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","article-title":"Targeting the TGFbeta pathway for cancer therapy","volume":"147","author":"Neuzillet","year":"2015","journal-title":"Pharmacol Ther"},{"key":"2021052111091474800_ref15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGFbeta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arr.2017.02.004","article-title":"Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation","volume":"36","author":"Rahimifard","year":"2017","journal-title":"Ageing Res Rev"},{"key":"2021052111091474800_ref17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N Engl J Med"},{"key":"2021052111091474800_ref19","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"2021052111091474800_ref20","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/mnfr.201300102","article-title":"Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway","volume":"57","author":"Speciale","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"2021052111091474800_ref21","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.addr.2012.12.004","article-title":"Drug target inference through pathway analysis of genomics data","volume":"65","author":"Ma","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"2021052111091474800_ref22","doi-asserted-by":"crossref","first-page":"D948","DOI":"10.1093\/nar\/gky868","article-title":"The comparative Toxicogenomics database: update 2019","volume":"47","author":"Davis","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref23","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkv1283","article-title":"CancerResource\u2013updated database of cancer-relevant proteins, mutations and interacting drugs","volume":"44","author":"Gohlke","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref24","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-pharmtox-010611-134520","article-title":"Systems pharmacology: network analysis to identify multiscale mechanisms of drug action","volume":"52","author":"Zhao","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2021052111091474800_ref26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/154065803322302826","article-title":"Advances in high content screening for drug discovery","volume":"1","author":"Giuliano","year":"2003","journal-title":"Assay Drug Dev Technol"},{"key":"2021052111091474800_ref27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1359-6446(98)01281-1","article-title":"Genomic technologies in drug discovery and development","volume":"4","author":"Hughes","year":"1999","journal-title":"Drug Discov Today"},{"key":"2021052111091474800_ref28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrd710","article-title":"Toxicogenomics and drug discovery: will new technologies help us produce better drugs?","volume":"1","author":"Ulrich","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2021052111091474800_ref29","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","author":"Yang","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref30","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref31","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2021052111091474800_ref32","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/bioinformatics\/bts502","article-title":"FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment","volume":"28","author":"Ma","year":"2012","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/bioinformatics\/bts285","article-title":"iFad: an integrative factor analysis model for drug-pathway association inference","volume":"28","author":"Ma","year":"2012","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2164-10-277","article-title":"CellMiner: a relational database and query tool for the NCI-60 cancer cell lines","volume":"10","author":"Shankavaram","year":"2009","journal-title":"BMC Genomics"},{"key":"2021052111091474800_ref35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1109\/TCBB.2015.2462344","article-title":"Efficient drug-pathway association analysis via integrative penalized matrix decomposition","volume":"13","author":"Li","year":"2016","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"2021052111091474800_ref36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/srep01445","article-title":"CancerDR: cancer drug resistance database","volume":"3","author":"Kumar","year":"2013","journal-title":"Sci Rep"},{"key":"2021052111091474800_ref37","doi-asserted-by":"crossref","first-page":"D351","DOI":"10.1093\/nar\/gkm843","article-title":"ChemBank: a small-molecule screening and cheminformatics resource database","volume":"36","author":"Seiler","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref38","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12918-017-0480-7","article-title":"Identifying drug-pathway association pairs based on L2,1-integrative penalized matrix decomposition","volume":"11","author":"Liu","year":"2017","journal-title":"BMC Syst Biol"},{"key":"2021052111091474800_ref40","doi-asserted-by":"crossref","first-page":"D685","DOI":"10.1093\/nar\/gkq1039","article-title":"Pathway commons, a web resource for biological pathway data","volume":"39","author":"Cerami","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2021052111091474800_ref41","first-page":"733","article-title":"Bayesian factor regression models in the \u201clarge p, small n\u201d paradigm","volume":"7","author":"Bernardo","year":"2003","journal-title":"Bayesian statistics"},{"key":"2021052111091474800_ref42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2105-8-61","article-title":"Factor analysis for gene regulatory networks and transcription factor activity profiles","volume":"8","author":"Pournara","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"2021052111091474800_ref43","doi-asserted-by":"crossref","first-page":"48075","DOI":"10.18632\/oncotarget.18254","article-title":"Identifying drug-pathway association pairs based on L1L2,1-integrative penalized matrix decomposition","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"2021052111091474800_ref44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.compbiolchem.2018.11.026","article-title":"Integrative graph regularized matrix factorization for drug-pathway associations analysis","volume":"78","author":"Dai","year":"2019","journal-title":"Comput Biol Chem"},{"key":"2021052111091474800_ref45","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1039\/C4MB00199K","article-title":"Drug-pathway interaction prediction via multiple feature fusion","volume":"10","author":"Song","year":"2014","journal-title":"Mol Biosyst"},{"key":"2021052111091474800_ref46","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1093\/bioinformatics\/btr500","article-title":"Gaussian interaction profile kernels for predicting drug-target interaction","volume":"27","author":"Laarhoven","year":"2011","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref47","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/bioinformatics\/btp433","article-title":"Supervised prediction of drug-target interactions using bipartite local models","volume":"25","author":"Bleakley","year":"2009","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref48","doi-asserted-by":"crossref","first-page":"i232","DOI":"10.1093\/bioinformatics\/btn162","article-title":"Prediction of drug-target interaction networks from the integration of chemical and genomic spaces","volume":"24","author":"Yamanishi","year":"2008","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/minf.201500033","article-title":"Inferring association between compound and pathway with an improved ensemble learning method","volume":"34","author":"Song","year":"2015","journal-title":"Mol Inform"},{"key":"2021052111091474800_ref50","volume-title":"Proceedings of the ninth international workshop on Machine learning","author":"Kira","year":"1992"},{"key":"2021052111091474800_ref51","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2217\/pgs.13.162","article-title":"Predicting drug-target interaction networks of human diseases based on multiple feature information","volume":"14","author":"Yu","year":"2013","journal-title":"Pharmacogenomics"},{"key":"2021052111091474800_ref52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/15476286.2017.1312226","article-title":"RKNNMDA: ranking-based KNN for MiRNA-disease association prediction","volume":"14","author":"Chen","year":"2017","journal-title":"RNA Biol"},{"key":"2021052111091474800_ref53","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/bioinformatics\/bts504","article-title":"Positive-unlabeled learning for disease gene identification","volume":"28","author":"Yang","year":"2012","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.compbiolchem.2014.08.019","article-title":"Exploring the complexity of pathway-drug relationships using latent Dirichlet\u00a0allocation","volume":"53","author":"Pratanwanich","year":"2014","journal-title":"Comput Biol Chem"},{"key":"2021052111091474800_ref55","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1073\/pnas.0307752101","article-title":"Finding scientific topics","volume":"101","author":"Griffiths","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021052111091474800_ref56","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1073\/pnas.1000488107","article-title":"Solving the apparent diversity-accuracy dilemma of recommender systems","volume":"107","author":"Zhou","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021052111091474800_ref57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/bib\/bbx130","article-title":"MicroRNAs and complex diseases: from experimental results to computational models","volume":"20","author":"Chen","year":"2019","journal-title":"Brief Bioinform"},{"key":"2021052111091474800_ref58","first-page":"558","article-title":"Long non-coding RNAs and complex diseases: from experimental results to computational models","volume":"18","author":"Chen","year":"2017","journal-title":"Brief Bioinform"},{"key":"2021052111091474800_ref59","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/bioinformatics\/btv039","article-title":"Prediction of potential disease-associated microRNAs based on random walk","volume":"31","author":"Xuan","year":"2015","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref60","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/bioinformatics\/bty333","article-title":"BNPMDA: bipartite network projection for MiRNA-disease association prediction","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref61","doi-asserted-by":"crossref","first-page":"e1005455","DOI":"10.1371\/journal.pcbi.1005455","article-title":"PBMDA: a novel and effective path-based computational model for miRNA-disease association prediction","volume":"13","author":"You","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2021052111091474800_ref62","first-page":"807","article-title":"ELLPMDA: ensemble learning and link prediction for miRNA-disease association prediction","volume":"15","author":"Chen","year":"2018","journal-title":"RNA Biol"},{"key":"2021052111091474800_ref63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13321-018-0284-9","article-title":"Inferring potential small molecule-miRNA association based on triple layer heterogeneous network","volume":"10","author":"Qu","year":"2018","journal-title":"J Chem"},{"key":"2021052111091474800_ref64","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/bioinformatics\/btv417","article-title":"Identifying novel associations between small molecules and miRNAs based on integrated molecular networks","volume":"31","author":"Lv","year":"2015","journal-title":"Bioinformatics"},{"key":"2021052111091474800_ref65","first-page":"47","article-title":"MicroRNA-small molecule association identification: from experimental results to computational models","volume":"21","author":"Chen","year":"2020","journal-title":"Brief Bioinform"},{"key":"2021052111091474800_ref66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.omtn.2018.12.002","article-title":"In Silico prediction of small molecule-miRNA associations based on the HeteSim algorithm","volume":"14","author":"Qu","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"2021052111091474800_ref67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1158140","article-title":"Drug target identification using side-effect similarity","volume":"321","author":"Campillos","year":"2008","journal-title":"Science"},{"key":"2021052111091474800_ref68","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1039\/c2mb00002d","article-title":"Drug-target interaction prediction by random walk on the heterogeneous network","volume":"8","author":"Chen","year":"2012","journal-title":"Mol Biosyst"},{"key":"2021052111091474800_ref69","doi-asserted-by":"crossref","first-page":"13186","DOI":"10.1038\/srep13186","article-title":"Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"2021052111091474800_ref70","doi-asserted-by":"crossref","first-page":"16840","DOI":"10.1038\/srep16840","article-title":"KATZLDA: KATZ measure for the lncRNA-disease association prediction","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"2021052111091474800_ref71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12967-018-1722-1","article-title":"A heterogeneous label propagation approach to explore the potential associations between miRNA and disease","volume":"16","author":"Chen","year":"2018","journal-title":"J Transl Med"},{"key":"2021052111091474800_ref72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jbi.2017.03.006","article-title":"Heter-LP: a heterogeneous label propagation algorithm and its application in drug repositioning","volume":"68","author":"Lotfi Shahreza","year":"2017","journal-title":"J Biomed Inform"},{"key":"2021052111091474800_ref73","first-page":"670949","article-title":"Systematic analysis of the associations between adverse drug reactions and pathways","volume":"2015","author":"Chen","year":"2015","journal-title":"Biomed Res Int"},{"key":"2021052111091474800_ref74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1109\/TNB.2014.2319158","article-title":"Linking biochemical pathways and networks to adverse drug reactions","volume":"13","author":"Zheng","year":"2014","journal-title":"IEEE Trans Nanobioscience"},{"key":"2021052111091474800_ref75","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1039\/C5MB00444F","article-title":"An integrated network platform for contextual prioritization of drugs and pathways","volume":"11","author":"Segura-Cabrera","year":"2015","journal-title":"Mol Biosyst"},{"key":"2021052111091474800_ref76","doi-asserted-by":"crossref","first-page":"e1004975","DOI":"10.1371\/journal.pcbi.1004975","article-title":"NLLSS: predicting synergistic drug combinations based on semi-supervised learning","volume":"12","author":"Chen","year":"2016","journal-title":"PLoS Comput Biol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/3\/bbaa061\/37966652\/bbaa061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/3\/bbaa061\/37966652\/bbaa061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T11:09:46Z","timestamp":1621595386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbaa061\/5835554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa061","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2020,5,11]]},"article-number":"bbaa061"}}